Registry-Based Surveillance of Severe Acute Respiratory Infections in Norway During 2021-2024
- PMID: 39950571
- PMCID: PMC11826439
- DOI: 10.1111/irv.70080
Registry-Based Surveillance of Severe Acute Respiratory Infections in Norway During 2021-2024
Abstract
Background: In 2021, the Norwegian Institute of Public Health established temporary registry-based surveillance of severe acute respiratory infections (SARI). We aimed to describe the surveillance system and evaluate selected attributes to inform the establishment of a permanent SARI surveillance system.
Methods: SARI cases were defined using ICD-10 discharge codes from national health and administrative registries, including codes for acute upper or lower respiratory infection (URI and LRI), COVID-19, acute respiratory distress syndrome, pertussis or otitis media. Data from polymerase chain reaction (PCR) analyses were available for 10 respiratory pathogens including SARS-CoV-2, influenza virus and respiratory syncytial virus (RSV). We included data from 28 September 2020 to 31 March 2024 and calculated the following parameters: the proportion of cases tested for SARS-CoV-2, influenza virus and/or RSV; time between admission and registration of a SARI-related ICD-10 code; and proportion of cases with URI, LRI and COVID-19.
Results: We identified 214,730 SARI cases, of whom 82%, 73% and 53% were tested for SARS-CoV-2, influenza virus and RSV. Case peaks were predominantly driven by one or a combination of these pathogens. Median time between admission and a registered SARI diagnostic code was 5 (lower-upper quartile 3-10) days. Nowcasting and alternative case definitions for SARI with COVID-19, influenza and RSV improved the timeliness. The ICD-10 codes for LRIs and COVID-19 captured only ~55% of the cases in the age group of 0-29 years compared to the routine case definition, where URIs were included.
Conclusions: Registry-based SARI surveillance provides timely data for handling epidemics of respiratory infections in Norway. We recommend establishing a permanent SARI surveillance system.
Keywords: COVID‐19; RSV; hospitalisation; influenza; registry‐based surveillance; severe acute respiratory infection (SARI).
© 2025 The Author(s). Influenza and Other Respiratory Viruses published by John Wiley & Sons Ltd.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures
References
-
- World Health Organization , “Up to 650 000 People Die of Respiratory Diseases Linked to Seasonal Flu Each Year,” (2017), https://www.who.int/news/item/13‐12‐2017‐up‐to‐650‐000‐people‐die‐of‐res....
-
- “Operational Considerations for Respiratory Virus Surveillance in Europe,” Copenhagen: WHO Regional Office for Europe and Stockholm: European Centre for Disease Prevention and Control, (2022).
-
- Epiconcept , “SARI Monitoring,” https://www.epiconcept.fr/en/epidemio‐project/sari‐surveillance/.
Publication types
MeSH terms
Grants and funding
- ECD.13350/European Centre for Disease Prevention and Control
- ECD.15029/European Centre for Disease Prevention and Control
- ECD.13629/European Centre for Disease Prevention and Control
- ECD.14898/European Centre for Disease Prevention and Control
- ECD.16380/European Centre for Disease Prevention and Control
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
